IA
ROIV icon

IFG Advisory’s Roivant Sciences ROIV Stock Holding History

IFG Advisory’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-29,869
Closed -$452K – 794
2025
Q3 		$452K Buy
29,869
+7,269
+32% +$90K 0.02% 517
2025
Q2 		$255K Buy
+22,600
New +$245K 0.01% 654
2025
Q1 		– Sell
-23,260
Closed -$275K – 719
2024
Q4 		$275K Buy
23,260
+3,055
+15% +$36.1K 0.02% 550
2024
Q3 		$233K Buy
+20,205
New +$230K 0.01% 359

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

IFG Advisory's ROIV Position: Q4 2025 in Review

IFG Advisory sold out of Roivant Sciences (ROIV) in Q4 2025, closing a stake of 29,869 shares — an estimated $452K sold.

IFG Advisory first reported a position in ROIV in Q3 2024 and held it in 4 quarters. The position peaked at $452K in Q3 2025. 399 funds tracked by Wall St. Rank hold ROIV as of Q4 2025.

  • IFG Advisory reported no remaining Roivant Sciences position as of Q4 2025 after selling out during the quarter.
  • IFG Advisory sold 29,869 Roivant Sciences shares in Q4 2025, an estimated $452K.
  • IFG Advisory first reported a position in Roivant Sciences in Q3 2024 and held it in 4 quarters.
  • IFG Advisory's Roivant Sciences position peaked at $452K in Q3 2025.
  • 399 funds tracked by Wall St. Rank held Roivant Sciences as of Q4 2025.

Based on IFG Advisory's 13F filing for Q4 2025, filed 10 Feb 2026.